A digest from evidence-based Clinical Practice Guideline for Polycystic Kidney Disease 2020

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical and experimental nephrology 2021-12, Vol.25 (12), p.1292-1302
Hauptverfasser:	Nishio, Saori, Tsuchiya, Ken, Nakatani, Shinya, Muto, Satoru, Mochizuki, Toshio, Kawano, Haruna, Hanaoka, Kazushige, Hidaka, Sumi, Ichikawa, Daisuke, Ishikawa, Eiji, Uchiyama, Kiyotaka, Koshi-Ito, Eri, Hayashi, Hiroki, Makabe, Shiho, Ogata, Soshiro, Mitobe, Michihiro, Sekine, Akinari, Suwabe, Tatsuya, Kataoka, Hiroshi, Kai, Hirayasu, Kaneko, Yoshikatsu, Kurashige, Mahiro, Seta, Koichi, Shimazu, Keiji, Hama, Taketsugu, Miura, Kenichiro, Nakanishi, Koichi, Horie, Shigeo, Furuichi, Kengo, Okada, Hirokazu, Narita, Ichiei
Format:	Artikel
Sprache:	eng
Schlagworte:	Asymptomatic Biomarkers Clinical medicine Clinical practice guidelines Committees Cysts Evidence-Based Medicine Evidence-Based Practice Family medical history Genes Genetic disorders Guideline Hematuria Hospitals Humans Informatics Kidney diseases Medicine Medicine & Public Health Mutation Nephrology Pain Patients Polycystic kidney Polycystic Kidney Diseases - diagnosis Polycystic Kidney Diseases - genetics Polycystic Kidney Diseases - therapy Polycystic Kidney, Autosomal Dominant - diagnosis Polycystic Kidney, Autosomal Dominant - drug therapy Ultrasonic imaging Urology Womens health Young adults
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!